Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Public ClinicalTrials.gov record NCT03684642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 56-week, Multicenter, Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly Compared to Dulaglutide Once Weekly in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Study identification
- NCT ID
- NCT03684642
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 908 participants
Conditions and interventions
Conditions
Interventions
- Background therapy Metformin Drug
- Dulaglutide Drug
- Efpeglenatide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 25, 2018
- Primary completion
- Oct 12, 2020
- Completion
- Nov 16, 2020
- Last update posted
- Oct 31, 2021
2018 – 2020
United States locations
- U.S. sites
- 30
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 8400038 | Birmingham | Alabama | 35211 | — |
| Investigational Site Number 8400035 | Chandler | Arizona | 85224 | — |
| Investigational Site Number 8400005 | Glendale | Arizona | 85306 | — |
| Investigational Site Number 8400054 | Peoria | Arizona | 85381 | — |
| Investigational Site Number 8400057 | Huntington Park | California | 90255 | — |
| Investigational Site Number 8400009 | Los Angeles | California | 90057 | — |
| Investigational Site Number 8400007 | San Diego | California | 92120 | — |
| Investigational Site Number 8400045 | Spring Valley | California | 91978 | — |
| Investigational Site Number 8400040 | Tustin | California | 92780 | — |
| Investigational Site Number 8400026 | Van Nuys | California | 91405 | — |
| Investigational Site Number 8400050 | Waterbury | Connecticut | 06708 | — |
| Investigational Site Number 8400055 | Orlando | Florida | 32825 | — |
| Investigational Site Number 8400041 | Pembroke Pines | Florida | 33026 | — |
| Investigational Site Number 8400025 | Lawrenceville | Georgia | 30044 | — |
| Investigational Site Number 8400060 | Meridian | Idaho | 83642 | — |
| Investigational Site Number 8400059 | Skokie | Illinois | 60077 | — |
| Investigational Site Number 8400044 | Lexington | Kentucky | 40503 | — |
| Investigational Site Number 8400061 | Boston | Massachusetts | 02115 | — |
| Investigational Site Number 8400001 | Bridgeton | New Jersey | 08302 | — |
| Investigational Site Number 8400039 | New Windsor | New York | 12553 | — |
| Investigational Site Number 8400028 | Burlington | North Carolina | 27215 | — |
| Investigational Site Number 8400036 | Morehead City | North Carolina | 28557 | — |
| Investigational Site Number 8400013 | Maumee | Ohio | 43537 | — |
| Investigational Site Number 8400014 | Goose Creek | South Carolina | 29445 | — |
| Investigational Site Number 8400030 | Dallas | Texas | 75230 | — |
| Investigational Site Number 8400020 | San Antonio | Texas | 78218 | — |
| Investigational Site Number 8400043 | San Antonio | Texas | 78229 | — |
| Investigational Site Number 8400053 | San Antonio | Texas | 78258 | — |
| Investigational Site Number 8400037 | Layton | Utah | 84041 | — |
| Investigational Site Number 8400049 | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03684642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 31, 2021 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03684642 live on ClinicalTrials.gov.